R. Hamor
Array BioPharma (United States) · 6 works · 649 citations · h-index 6
Top works
- The Radiologic Manifestations of Legionnaire's Disease
- Selective RET kinase inhibition for patients with RET-altered cancers
- Persistently Positive Culture Results in a Patient with Community-Acquired Pneumonia Due to Legionella pneumophila
- Stereophotogrammetric Method For Breast Cancer Detection
- The development of a potent, KDR/VEGFR2-sparing RET kinase inhibitor for treating patients with RET-dependent cancers
- The development of LOXO-195, a second generation TRK kinase inhibitor that overcomes acquired resistance to 1st generation inhibitors observed in patients with TRK-fusion cancers